Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Israel Fights Back on Teva Job Cuts - WSJ
Teva Shares Plunge as CEO Steps Down From Israeli Pharmaceutical Giant – The Forward
Buffett's Berkshire Hathaway doubles shares of Teva - JNS.org
Opioid lawsuit concerns hit Teva - Globes
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's $40.5B record deal
Teva's profit beats forecasts, shares jump - Israel News - The Jerusalem Post
Teva stock gains on new growth strategy; Evercore upgrades | Seeking Alpha
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva's Stock Price Surge Against Its Predictable Woes
Teva Falls Hard, Loses Title as Israel's Biggest Firm - TheStreet
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule | Business Wire
Teva Stock: What We Know, And Don't, About The Adderall Shortage | Investor's Business Daily
